<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Hum Mol Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">Hum. Mol. Genet</journal-id>
<journal-id journal-id-type="publisher-id">hmg</journal-id>
<journal-title-group>
<journal-title>Human Molecular Genetics</journal-title>
</journal-title-group>
<issn pub-type="ppub">0964-6906</issn>
<issn pub-type="epub">1460-2083</issn>
<publisher>
<publisher-name>Oxford University Press</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28204491</article-id>
<article-id pub-id-type="pmc">6075589</article-id>
<article-id pub-id-type="doi">10.1093/hmg/ddx034</article-id>
<article-id pub-id-type="publisher-id">ddx034</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Fragile X related protein 1 (FXR1P) regulates proliferation of adult neural stem cells</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Patzlaff</surname>
<given-names>Natalie E.</given-names>
</name>
<xref ref-type="aff" rid="ddx034-aff1">1</xref>
<xref ref-type="aff" rid="ddx034-aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nemec</surname>
<given-names>Kelsey M.</given-names>
</name>
<xref ref-type="aff" rid="ddx034-aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Malone</surname>
<given-names>Sydney G.</given-names>
</name>
<xref ref-type="aff" rid="ddx034-aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Yue</given-names>
</name>
<xref ref-type="aff" rid="ddx034-aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhao</surname>
<given-names>Xinyu</given-names>
</name>
<xref ref-type="aff" rid="ddx034-aff1">1</xref>
<xref ref-type="aff" rid="ddx034-aff2">2</xref>
<xref ref-type="aff" rid="ddx034-aff3">3</xref>
<xref ref-type="corresp" rid="ddx034-cor1"></xref>
<!--<email>xinyu.zhao@wisc.edu</email>-->
</contrib>
</contrib-group>
<aff id="ddx034-aff1">
<label>1</label>Waisman Center, University of Wisconsin-Madison, Madison, WI 53705, USA</aff>
<aff id="ddx034-aff2">
<label>2</label>Molecular and Cellular Pharmacology Graduate Program, University of Wisconsin-Madison, Madison, WI 53705, USA</aff>
<aff id="ddx034-aff3">
<label>3</label>Department of Neuroscience, University of Wisconsin-Madison, Madison, WI 53705, USA</aff>
<author-notes>
<corresp id="ddx034-cor1"><label>*</label>To whom correspondence should be addressed at: Waisman Center and Department of Neuroscience, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI 53705, USA. Tel: +60 82639906; Fax: +60 88903479; Email: <email>xinyu.zhao@wisc.edu</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<day>01</day>
<month>4</month>
<year>2017</year>
</pub-date>
<pub-date iso-8601-date="2017-02-15" pub-type="epub">
<day>15</day>
<month>2</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>4</month>
<year>2018</year>
</pub-date>
<!-- PMC Release delay is 12 months and
						0 days and was based on the <pub-date
						pub-type="ppub"/>. -->
<volume>26</volume>
<issue>7</issue>
<fpage>1340</fpage>
<lpage>1352</lpage>
<history>
<date date-type="received">
<day>10</day>
<month>11</month>
<year>2016</year>
</date>
<date date-type="rev-recd">
<day>16</day>
<month>1</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>19</day>
<month>1</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>Â© The Author 2017. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com</copyright-statement>
<copyright-year>2017</copyright-year>
</permissions>
<self-uri xlink:href="ddx034.pdf"></self-uri>
<abstract>
<title>Abstract</title>
<p>Fragile X related protein 1 (FXR1P) is a member of the fragile X family of RNA-binding proteins, which includes FMRP and FXR2P. Both FMRP and FXR2P regulate neurogenesis, a process affected in a number of neurological and neuropsychiatric disorders, including fragile X syndrome. Although FXR1P has been implicated in various developmental processes and neuropsychiatric diseases, its role in neurodevelopment is not well understood. The goal of the present study was to elucidate the function of FXR1P in adult neurogenesis. We used an inducible mouse model that allows us to investigate how FXR1P deficiency in adult neural stem cells (aNSCs) affects proliferation and neuronal differentiation. Deletion of FXR1 in aNSCs resulted in fewer adult-born cells in the dentate gyrus (DG) overall, reducing populations across different stages of neurogenesis, including radial glia-like cells, intermediate progenitors, neuroblasts, immature neurons and neurons. We hypothesized that this reduction in new cell numbers resulted from impaired proliferation, which we confirmed both <italic>in vivo</italic> and <italic>in vitro</italic>. We discovered that FXR1P-deficient aNSCs have altered expression of a select number of cell-cycle genes, and we identified the mRNA of cyclin-dependent kinase inhibitor 1A (<italic>Cdkn1a, p21</italic>) as a direct target of FXR1P. Restoration of p21 mRNA to wild-type levels rescued the proliferation deficit in cells lacking FXR1P, demonstrating that p21 is a mediator of FXR1P in aNSCs. These results indicate that FXR1P plays an important role in regulating aNSC self-renewal and maintenance in the adult brain, which may have implications for a number of neurodevelopmental and psychiatric disorders.</p>
</abstract>
<funding-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">National Institutes of Health</named-content>
<named-content content-type="funder-identifier">10.13039/100000002</named-content>
</funding-source>
<award-id>MH080434</award-id>
<award-id>MH07897</award-id>
<award-id>R21NS095632</award-id>
<award-id>P30HD03352</award-id>
<award-id>U54 HD090256</award-id>
<award-id>F31MH103945</award-id>
<award-id>T32 GM008688</award-id>
</award-group>
</funding-group>
<counts>
<page-count count="13"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>